NeOnc Technologies Holdings is trading at $3.62 (5.3% up) as speculative biotech names see a risk-on move following recent volatility.

  • The move comes despite the broader biotech sector ETF (XBI) trading lower, suggesting isolated strength in smaller-cap names.
  • There are no fresh company-specific headlines, filings, or analyst actions driving the price action.
  • Market sentiment and dip-buying appear to be the primary catalysts for the current upside.